RE-AIM dimension | Example areas to be studied | Outcome (implementation or participant level) | Key features and subgroups associated with outcomes | Data sources |
---|---|---|---|---|
Reach | Changes in the population served | Implementation: Program level rates of enrollment and discharge across OTNY | Geographic areas with high and low COVID penetration. | Clinician-reported data aggregated to the program level |
Effectiveness | Participant level: Participant characteristics at enrollment to OTNY | Referral source (e.g., inpatient unit), duration of untreated psychosis (DUP), symptoms, additional variables as identified in Aims 1 and 2 | Clinician-reported data and participant self-report data | |
Effectiveness | Participant level: Participant features at time of discharge/disengagement from OTNY | Length of stay in OnTrackNY; symptoms, occupational and social functioning; use of telehealth services; satisfaction with services; other factors as identified in Aims 1 and 2 | Clinician-reported data and participant self-report data | |
Effectiveness | Changes in participant outcomes | Participant level: Symptoms, social and occupational functioning, work/school participation, suicidality, and other factors identified in Aims 1 and 2 | Clinical characteristics at enrollment, age, gender, race/ethnicity, DUP, educational attainment, program site, presence of identified modifications, other factors as identified in Aims 1 & 2 | Clinician and participant self-reported data |
Implementation | Changes in how and which services are implemented | Implementation level: Frequency of utilization of OTNY services overall and with particular team members (e.g., peer support, supported employment and education services) | Presence of identified modifications in a clinic (e.g., telehealth interventions), programs where staffing was affected (e.g., FTE per team), participant utilization of modifications, fidelity to the CSC model, other factors identified in Aims 1 & 2 | Program-level data and clinician-reported data |